Rock Springs Capital Management LP 13D/13G Filings for Xilio Therapeutics, Inc. (XLO)

Rock Springs Capital Management LP 13D and 13G filings for Xilio Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-05-15
10:48 am
Sale
2025-03-3113GXILIO THERAPEUTICS INC
XLO
Rock Springs Capital Management LP0
0.000%
-214,518decrease
(Position Closed)
Filing
2024-11-12
4:50 pm
Unchanged
2024-09-3013GXILIO THERAPEUTICS INC
XLO
Rock Springs Capital Management LP214,518
6.830%
0
(Unchanged)
Filing
2024-04-05
2:51 pm
Purchase
2024-03-2713GXILIO THERAPEUTICS INC
XLO
Rock Springs Capital Management LP214,518
8.710%
111,607increase
(+108.45%)
Filing